Department of Clinical Science and Education, Karolinska Institutet, Women's Clinic, Sodersjukhuset, Sweden.
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Biomed Res Int. 2017;2017:6840592. doi: 10.1155/2017/6840592. Epub 2017 Sep 18.
One great challenge in obstetric care is labor inductions. Misoprostol has advantages in being cheap and stable at room temperature and available in resource-poor settings.
Retrospective cohort study of 4002 singleton pregnancies with a gestational age ≥34 w at Sodersjukhuset, Stockholm, during 2009-2010 and 2012-2013. Previously used methods of labor induction were compared with misoprostol given as a solution to drink, every second hour. Main outcome is as follows: Cesarean Section (CS) rate, acid-base status in cord blood, Apgar score < 7,5', active time of labor, and blood loss > 1500 ml (PPH).
The proportion of CS decreased from 26% to 17% when orally given solution of misoprostol was introduced at the clinic ( < 0.001). No significant difference in the frequency of low Apgar score ( = 0.3), low aPh in cord blood ( = 0.1), or PPH ( = 0.4) between the different methods of induction was studied. After adjustment for different risk factor for CS the only method of induction which was associated with CS was dinoproston (Propess®) (aor = 2.9 (1.6-5.2)).
Induction of labor with misoprostol, given as an oral solution to drink every second hour, gives a low rate of CS, without affecting maternal or fetal outcome.
产科护理的一大挑战是引产。米索前列醇具有价格低廉、在室温下稳定且在资源匮乏的环境中可获得的优势。
这是一项在斯德哥尔摩 Sodersjukhuset 进行的回顾性队列研究,纳入了 2009-2010 年和 2012-2013 年期间 4002 例胎龄≥34 周的单胎妊娠。比较了之前使用的引产方法与每两小时口服米索前列醇溶液的方法。主要结局如下:剖宫产率、脐带血酸碱状态、Apgar 评分<7.5、产程活跃时间和出血量>1500ml(产后出血)。
当在诊所引入口服米索前列醇溶液时,剖宫产率从 26%降至 17%(<0.001)。不同引产方法之间的 Apgar 评分低(=0.3)、脐带血 aPh 低(=0.1)或产后出血(=0.4)的发生率无显著差异。在调整了剖宫产的不同危险因素后,唯一与剖宫产相关的引产方法是地诺前列酮(Propess®)(aOR=2.9(1.6-5.2))。
口服米索前列醇溶液每两小时一次引产可降低剖宫产率,且不影响母婴结局。